Clinical trials
Phase 4 Ischemic Stroke trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2015 | 3 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 7 |
| 2023 | 5 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dongzhimen Hospital, Beijing | 3 |
| Asan Medical Center | 2 |
| First Affiliated Hospital, Sun Yat-Sen University | 2 |
| Ajou University School of Medicine | 1 |
| Beijing Tiantan Hospital | 1 |
| City Hospitals Sunderland NHS Foundation Trust | 1 |
| Clinical Institute of the Brain, Russia | 1 |
| Far Eastern Memorial Hospital | 1 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 1 |
| Guangzhou University of Traditional Chinese Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemic Stroke | 39 |
| Stroke | 9 |
| Brain Ischemia | 5 |
| Intracranial Arteriosclerosis | 2 |
| Intracranial Hemorrhages | 2 |
| Nervous System Diseases | 2 |
| Arrhythmias, Cardiac | 1 |
| Atrial Fibrillation | 1 |
| Brain Infarction | 1 |
| Brain Injuries | 1 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.